$VTR

Ventas, Inc.

alphai earnings readsecond quarter 2026 · JUL 29Ventas Reports 2026 Second Quarter ResultsVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

2
1
0

No SEC Form 4 filings for $VTR in the last 30 days.

See all $VTR insider activity →
High

The Baby Boomers Are Turning 80—3 REITs Built to Cash In

Welltower (WELL), Ventas (VTR), and Omega Healthcare (OHI) are REITs benefiting from a demographic wave of aging baby boomers. Welltower reported Q2 2026 revenue of $3.54B, up 40.9% YoY, and raised FFO guidance. Ventas saw 9% YoY FFO growth and shifted focus to SHOP. Omega Healthcare improved AFFO and raised its dividend. All three companies are positioned to capitalize on increased demand for senior housing and skilled nursing facilities.

5 reasons to stay bullish on these dividend-paying assets, according to Morgan Stanley

Morgan Stanley's Ronald Kamdem expects senior housing REITs to continue outperforming due to aging population and high demand. Welltower (WELL) and American Healthcare REIT (AHR) are rated overweight, with price targets of $251 and implied upside, respectively. Ventas (VTR) is rated equal weight. All three REITs show strong occupancy and acquisition growth potential, with Welltower's dividend yield at 1.44%.

VTR sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning VTR (Ventas, Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.

Recent VTR coverage spans financial news, earnings and market movers.

What's driving VTR

alphai scores every news story that mentions VTR with an AI model for sentiment and relevance, and aggregates insider trades from Ventas, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VTR

Score
$WELLHighAI 8/10

The Baby Boomers Are Turning 80—3 REITs Built to Cash In

Welltower (WELL), Ventas (VTR), and Omega Healthcare (OHI) are REITs benefiting from a demographic wave of aging baby boomers. Welltower reported Q2 2026 revenue of $3.54B, up 40.9% YoY, and raised FFO guidance. Ventas saw 9% YoY FFO growth and shifted focus to SHOP. Omega Healthcare improved AFFO and raised its dividend. All three companies are positioned to capitalize on increased demand for senior housing and skilled nursing facilities.

$WELLMed

5 reasons to stay bullish on these dividend-paying assets, according to Morgan Stanley

Morgan Stanley's Ronald Kamdem expects senior housing REITs to continue outperforming due to aging population and high demand. Welltower (WELL) and American Healthcare REIT (AHR) are rated overweight, with price targets of $251 and implied upside, respectively. Ventas (VTR) is rated equal weight. All three REITs show strong occupancy and acquisition growth potential, with Welltower's dividend yield at 1.44%.

$WELLMed

Mizuho Names Top REITs as Senior Housing Sector Shows Strength

Mizuho identified Welltower Inc (WELL) and Ventas Inc (VTR) as top picks in the senior housing REIT sector, with price targets of $260 and $104 respectively. WELL trades at a premium multiple due to superior cash flow growth, while VTR shows strong revenue growth. Both companies reported Q2 2026 results, with WELL surpassing revenue forecasts but missing on EPS, and VTR meeting earnings expectations and exceeding revenue forecasts.

Ventas adds sustainability goals as it completes ‘highest-impact’ energy efficiency initiatives

Ventas, a real estate investment trust, updated its sustainability goals in its annual report, focusing on energy efficiency, water use, and waste reduction. The company completed high-impact energy initiatives and adjusted its 2030 energy reduction target. Ventas also integrated electrification and renewable goals into its net zero plan and is on track to reduce water use intensity in its senior housing portfolio by 20% from 2022 to 2030. The company has reduced waste by 17% since 2022 and aims

$VTRLow

Are Wall Street Analysts Bullish on Ventas Stock?

Cantor Fitzgerald analyst Richard Anderson kept an “Overweight” rating on Ventas and raised its price target to $102 from $97, citing continued confidence in the REIT’s growth prospects. The article notes a mean target of $100.87 and a Street-high target of $114, implying about 8% and 22.1% upside versus current levels.

$VTRMed

Ventas Q2 Earnings Call Highlights

Ventas (NYSE:VTR) reported Q2 call highlights: same-store revenue rose nearly 9% and operating expenses increased 5%, expanding NOI margins 210 bps to 31%. U.S. senior housing occupancy was 87% for its SHOP and 83% for non-same-store. It maintained 16% SHOP NOI growth outlook, raised full-year occupancy growth to 300 bps, and lifted normalized FFO guidance midpoint to $3.88/share.

Related tickers